Feb 12 (Reuters) - The U.S. Food and Drug Administration said on Thursday it has approved labeling changes to six menopause ...

The FDA has approved drug label changes to six menopausal hormone replacement therapies (HRT), according to a recent news release. This was done to clarify risks for taking these drugs, specifically ...

Authors say a personalized approach to hormone therapy use with regular reassessment of risks and benefits is needed.

The U.S. Food and Drug Administration has approved drug labeling changes to six menopausal hormone therapy products, also known as hormone replacement therapy (HRT), to clarify risk considerations for ...

The new labeling for the products does not include risk statements related to cardiovascular disease, breast cancer and probable dementia, the agency said.

Tirzepatide users on hormone therapy had added improvements in weight, cardiometabolic mar ...

Menopause can have profound effects on heart health, yet many people are unaware of this important connection. The hormonal shifts occurring during menopause mark the end of a woman’s reproductive ...

Hormone therapy (HT) has proven effective for managing hot flashes and other common menopause symptoms, but questions remain ...

A new study finds that hormone therapy may help women manage hot flashes and improve quality of life into their seventies and even eighties. Even after menopause, a significant number of women in ...

A new scientific analysis found hormone therapy may be helpful for cardiovascular health in menopause. The study adds to other evidence that suggests hormone therapy can help heart health. Doctors ...

Postmenopausal women who have used hormone therapy may be biologically younger than those who have not, a retrospective study of women in the U.K. Biobank suggested. Examining nine biomarkers linked ...

Researchers have found in a retrospective cohort study that postmenopausal women with obesity treated with tirzepatide ...